XML 74 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated statement of income - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Profit or loss [abstract]      
Revenue $ 4,171 $ 4,336 $ 3,946 [1]
Cost of sales (1,171) (1,201) (1,117) [1]
Gross profit 3,000 3,135 2,829 [1]
Operating expenses (1,505) (1,604) (1,616) [1]
Depreciation (890) (825) (662) [1]
Amortization (318) (275) (140) [1]
Share of profit in the joint ventures in Guatemala and Honduras 171 179 154 [1]
Other operating income (expenses), net (12) (34) 75 [1]
Operating profit 446 575 640 [1]
Interest and other financial expenses (624) (564) (367) [1]
Interest and other financial income 13 20 21 [1]
Other non-operating (expenses) income, net (106) 227 (39) [1]
Profit (loss) from other joint ventures and associates, net (1) (40) (136) [1]
Profit (loss) before taxes from continuing operations (271) 218 119 [1]
Tax (charge) credit, net (102) (120) (112) [1]
Profit (loss) from continuing operations (373) 97 7 [1]
Profit (loss) from discontinued operations, net of tax (12) 57 (33) [1]
Net profit (loss) for the period (385) 154 (26) [2]
Net profit (loss) for the year Attributable to:      
Owners of the Company (344) 149 (10) [1]
Non-controlling interests $ (41) $ 5 $ (16) [1]
Basic and diluted (US$ per common share) (ii)      
— from continuing operations (usd per share) [3] $ (3.28) $ 0.92 $ 0.23 [1]
— from discontinued operations (usd per share) [3] (0.12) 0.56 (0.33) [1]
— total (usd per share) [3] $ (3.40) $ 1.48 $ (0.10) [1]
[1] 2018 was not restated for the application of IFRS 16, as the Group elected the modified retrospective approach.
[2] 2018 was not restated for the application of IFRS 16, as the Group elected the modified retrospective approach.
[3] There are no dilutive potential ordinary shares